000 01410 a2200469 4500
005 20250513145835.0
264 0 _c19980901
008 199809s 0 0 eng d
022 _a0027-5107
024 7 _a10.1016/s0027-5107(97)00310-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFujiki, H
245 0 0 _aCancer inhibition by green tea.
_h[electronic resource]
260 _bMutation research
_cJun 1998
300 _a307-10 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a3T3 Cells
650 0 4 _aAnimals
650 0 4 _aAnticarcinogenic Agents
_xpharmacokinetics
650 0 4 _aBiological Availability
650 0 4 _aCatechin
_xanalogs & derivatives
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aNeoplasms
_xmetabolism
650 0 4 _aTea
_xchemistry
650 0 4 _aTumor Cells, Cultured
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
700 1 _aSuganuma, M
700 1 _aOkabe, S
700 1 _aSueoka, N
700 1 _aKomori, A
700 1 _aSueoka, E
700 1 _aKozu, T
700 1 _aTada, Y
700 1 _aSuga, K
700 1 _aImai, K
700 1 _aNakachi, K
773 0 _tMutation research
_gvol. 402
_gno. 1-2
_gp. 307-10
856 4 0 _uhttps://doi.org/10.1016/s0027-5107(97)00310-2
_zAvailable from publisher's website
999 _c9641180
_d9641180